# STRYKER CORP (SYK) FY2024 Q3 P&L / Income Statement

- Company: STRYKER CORP (SYK)
- Period: 2024-07-01 to 2024-09-30
- Filing: Q3 FY2024 10-Q, filed 2024-10-30, accession number 0000310764-24-000115
- Page: https://plicit.ai/financials/syk/fy2024-q3-income-statement
- Chart image: https://plicit.ai/charts/syk-fy2024-q3-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Product and Service

Income statement for 2024-07-01 through 2024-09-30. View: Segments by Product and Service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,494,000,000 US dollars
- **Cost of sales**: 1,977,000,000 US dollars
- **Gross profit**: 3,517,000,000 US dollars
- **Total operating expenses**: 2,432,000,000 US dollars
- **Operating income**: 1,085,000,000 US dollars
- **Other income (expense), net**: negative 42,000,000 US dollars
- **Earnings before income taxes**: 1,043,000,000 US dollars
- **Income taxes**: 209,000,000 US dollars
- **Net earnings**: 834,000,000 US dollars
- **MedSurg and Neurotechnology - Endoscopy**: 837,000,000 US dollars
- **MedSurg and Neurotechnology - Instruments**: 679,000,000 US dollars
- **MedSurg and Neurotechnology - Medical**: 938,000,000 US dollars
- **MedSurg and Neurotechnology - Neuro Cranial**: 441,000,000 US dollars
- **MedSurg and Neurotechnology - Neurovascular**: 329,000,000 US dollars
- **Orthopaedics and Spine - Hips**: 420,000,000 US dollars
- **Orthopaedics and Spine - Knees**: 570,000,000 US dollars
- **Orthopaedics and Spine - Other**: 127,000,000 US dollars
- **Orthopaedics and Spine - Spine**: 304,000,000 US dollars
- **Orthopaedics and Spine - Trauma and Extremities**: 849,000,000 US dollars
- **Research, development and engineering expenses**: 377,000,000 US dollars
- **Selling, general and administrative expenses**: 1,896,000,000 US dollars
- **Amortization of intangible assets**: 159,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography

- Page: https://plicit.ai/financials/syk/fy2024-q3-income-statement/revenue-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2024-q3-revenue-by-geography-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Geography. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,494,000,000 US dollars
- **Cost of sales**: 1,977,000,000 US dollars
- **Gross profit**: 3,517,000,000 US dollars
- **Total operating expenses**: 2,432,000,000 US dollars
- **Operating income**: 1,085,000,000 US dollars
- **Other income (expense), net**: negative 42,000,000 US dollars
- **Earnings before income taxes**: 1,043,000,000 US dollars
- **Income taxes**: 209,000,000 US dollars
- **Net earnings**: 834,000,000 US dollars
- **UNITED STATES**: 4,109,000,000 US dollars
- **International**: 1,385,000,000 US dollars
- **Research, development and engineering expenses**: 377,000,000 US dollars
- **Selling, general and administrative expenses**: 1,896,000,000 US dollars
- **Amortization of intangible assets**: 159,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/syk/fy2024-q3-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/syk-fy2024-q3-revenue-by-business-segment-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,494,000,000 US dollars
- **Cost of sales**: 1,977,000,000 US dollars
- **Gross profit**: 3,517,000,000 US dollars
- **Total operating expenses**: 2,432,000,000 US dollars
- **Operating income**: 1,085,000,000 US dollars
- **Other income (expense), net**: negative 42,000,000 US dollars
- **Earnings before income taxes**: 1,043,000,000 US dollars
- **Income taxes**: 209,000,000 US dollars
- **Net earnings**: 834,000,000 US dollars
- **MedSurg and Neurotechnology**: 3,224,000,000 US dollars
- **Orthopaedics and Spine**: 2,270,000,000 US dollars
- **Research, development and engineering expenses**: 377,000,000 US dollars
- **Selling, general and administrative expenses**: 1,896,000,000 US dollars
- **Amortization of intangible assets**: 159,000,000 US dollars
- **MedSurg and Neurotechnology costs (calculated)**: 2,300,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Orthopaedics and Spine costs (calculated)**: 1,627,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- **Reconciling items (calculated)**: 482,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/syk/fy2024-q3-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/syk-fy2024-q3-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2024-07-01 through 2024-09-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Net sales**: 5,494,000,000 US dollars
- **Cost of sales**: 1,977,000,000 US dollars
- **Gross profit**: 3,517,000,000 US dollars
- **Total operating expenses**: 2,432,000,000 US dollars
- **Operating income**: 1,085,000,000 US dollars
- **Other income (expense), net**: negative 42,000,000 US dollars
- **Earnings before income taxes**: 1,043,000,000 US dollars
- **Income taxes**: 209,000,000 US dollars
- **Net earnings**: 834,000,000 US dollars
- **MedSurg and Neurotechnology - UNITED STATES**: 2,503,000,000 US dollars
- **MedSurg and Neurotechnology - International**: 721,000,000 US dollars
- **Orthopaedics and Spine - UNITED STATES**: 1,606,000,000 US dollars
- **Orthopaedics and Spine - International**: 664,000,000 US dollars
- **Research, development and engineering expenses**: 377,000,000 US dollars
- **Selling, general and administrative expenses**: 1,896,000,000 US dollars
- **Amortization of intangible assets**: 159,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.